Report Overview

2023

Base Year

2017-2023

Historical Year

2024-2032

Forecast Year

Global Cancer Immunotherapy Market Outlook

The global cancer immunotherapy market size attained a value of USD 118.97 billion in 2023. The market is likely to grow at a CAGR of 11.6% during the forecast period of 2024-2032 to attain a value of USD 319.45 billion by 2032.

Global Cancer Immunotherapy Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Increasing Demand for Monoclonal Antibodies to Catalyse the Growth of the Global Cancer Immunotherapy Industry

Based on therapy type, the monoclonal antibodies segment is expected to hold a significant share in the global cancer immunotherapy industry during the forecast period. This growth can be attributed to the heightened implementation of monoclonal antibodies therapy in cancer treatment globally. Monoclonal antibodies are immune system proteins created in the lab. Antibodies help the immune system to identify disease-causing bacteria and viruses and target them. For example, rituximab binds to a protein called CD20 on B cells, a type of white blood cells, and some types of cancer cells, causing the immune system to attack them. These factors are estimated to drive the market growth in the forecast period.

North America to Possess a Substantial Market Share in the Global Cancer Immunotherapy Industry

North America is predicted to hold a considerable market share in the global cancer immunotherapy industry. This surge can be attributed to the increased adoption of cancer immunotherapy in the region. In addition, the growing prevalence of cancer in the region has enhanced the demand for immunotherapies. According to the statistics given by National Cancer Institute, as of January 2019, there were an estimated 16.9 million cancer survivors reported in the United States. Further, the number of cancer survivors is projected to increase to 22.2 million by 2030. These factors are estimated to drive the market growth in the region.

Cancer Immunotherapy: Market Segmentation

Cancer refers to diseases that can originate in any organ or tissue of the body where abnormal cells grow unnaturally and go beyond their usual boundaries to invade nearby body parts, also known as metastasizing. According to WHO, cancer is the second leading cause of death globally. Among men, lung, prostate, colorectal, stomach, and liver cancer are the most common types of cancer. In contrast, breast, colorectal, lung, cervical and thyroid cancer are the most common cancer types among women. In this regard, immunotherapy is a treatment for cancer that helps and supports a patient's immune system to fight cancer by providing a boost to the immune system's natural defences to locate and attack cancer cells in the body.

Global Cancer Immunotherapy Market by Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

By therapy type, the market is distributed into:

  • Monoclonal Antibodies
  • Cancer Vaccines
  • Immunomodulators
  • Immune Check Point Inhibitors
  • Others

On the basis of application, the industry can be categorised into:

  • Prostate Cancer
  • Breast Cancer 
  • Skin Cancer 
  • Lung Cancer
  • Others

Based on end use, the market can be segmented into:

  • Hospitals and Clinics
  • Cancer Research Centres
  • Others

The regional markets for the product include North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

Global Cancer Immunotherapy Market by Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

Heightened Prevalence of Cancer to Augment the Growth of the Global Cancer Immunotherapy Industry

According to the WHO statistics, cancer is the second leading cause of death globally, with around 9.6 million casualties reported in 2018. In 2020, the number of cancer cases reported was 19.3 million, and this number is estimated to rise to 30.2 million by 2040. Among these, the most commonly found cancer is breast cancer. In 2020, an estimated 2.3 million women were diagnosed with breast cancer and 685 000 deaths globally. Observing the growing prevalence of cancer worldwide, governments and international organisations are increasingly devising strategies and conceptualising initiatives to raise funds and awareness about cancer and its potential prevention. For instance, the WHO initiative, Global Breast Cancer Initiative (GBCI), aims to reduce the mortality rate by 2.5% every year, which would help to prevent 40% of cancer deaths by 2040. Their main objectives include health promotion for early detection, timely diagnosis, and comprehensive breast cancer management. Such developments are expected to drive market growth in the forecast period.

Key Industry Players in the Global Cancer Immunotherapy Market

The report gives a detailed analysis of the following key players in the global cancer immunotherapy market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Amgen Inc.
  • Astellas Pharma Inc.
  • AstraZeneca plc
  • Bayer AG
  • Bristol-Myers Squibb Company
  • F. Hoffmann-La Roche AG 
  • Others

The comprehensive EMR report provides an in-depth assessment of the industry based on the Porter's five forces model and SWOT analysis.

Key Highlights of the Report

REPORT FEATURES DETAILS
Base Year 2023
Historical Period 2017-2023
Forecast Period 2024-2032
Scope of the Report

Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:

  • Therapy Type
  • Application
  • Distribution Channels
  • End Use
  • Region
Breakup by Therapy Type
  • Monoclonal Antibodies
  • Cancer Vaccines
  • Immunomodulators
  • Immune Check Point Inhibitors
  • Others
Breakup by Application
  • Prostate Cancer
  • Breast Cancer
  • Skin Cancer
  • Lung Cancer
  • Melanoma
  • Others
Breakup by Distribution Channels
  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy
  • Others
Breakup by End Use
  • Hospitals & Clinics
  • Cancer Research Centers
Breakup by Region
  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa
Market Dynamics
  • Market Drivers and Constraints
  • SWOT Analysis
  • Porter’s Five Forces Model 
  • Key Demand Indicators
  • Key Price Indicators
  • Industry Events, Initiatives, and Trends 
  • Value Chain Analysis
Supplier Landscape
  • Market Structure
  • Company Profiles
    • Financial Analysis
    • Product Portfolio
    • Demographic Reach and Achievements
    • Mergers and Acquisitions
    • Certifications
Companies Covered
  • AstraZeneca
  • F. Hoffmann-La Roche Ltd
  • Amgen Inc.
  • Astellas Pharma Inc.
  • Bayer AG
  • Bristol-Myers Squibb Company
  • Novartis AG
  • Genentech, Inc (Roche)
  • Lilly
  • Johnson & Johnson Services, Inc
  • Immunocore, Ltd
  • Merck

*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*

Looking for specific insights?

Get in touch with us today for customized, data-driven solutions tailored to your unique requirements!

Key Questions Answered in the Report

The cancer immunotherapy Market was valued at USD 118.97 billion in 2023.

The market is expected to grow at a CAGR of 11.6% from 2024 to 2032 to reach a value of USD 319.45 billion by 2032.

The major drivers of the industry include rapidly growing geriatric global population, rising numbers of casualties of different cancer varieties, increased adoption of cancer immunotherapy and heightened implementation of monoclonal antibodies therapy in cancer treatment.

The key market trends guiding the industry's growth include the growing prevalence of cancer worldwide and government initiatives to raise funds and awareness about cancer and its potential prevention.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The market is divided based on therapy type into monoclonal antibodies, cancer vaccines, immunomodulators, and immune check point inhibitors, among others.

The significant applications include into prostate cancer, breast cancer, skin cancer, and lung cancer, among others.

The significant segments based on  end-use include hospitals and clinics and cancer research centres, among others.

The major players in the industry are Amgen Inc., Astellas Pharma Inc., AstraZeneca plc, Bayer AG, Bristol-Myers Squibb Company, and F. Hoffmann-La Roche AG., among others.

How To Order

Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.

Select License Type

Choose the right license for your needs and access rights.

Click on ‘Buy Now’

Add the report to your cart with one click and proceed to register.

Select Mode of Payment

Choose a payment option for a secure checkout. You will be redirected accordingly.

Pricing Plans

Purchase Full Report

Datasheet

 

USD 2,969

USD 2,699

tax inclusive*

  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

One User

USD 5,499

USD 4,999

tax inclusive*

  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

Five Users

USD 6,599

USD 5,999

tax inclusive*

  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

Unlimited Users

USD 7,699

USD 6,999

tax inclusive*

  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Connect For More Information

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.

We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.

Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.

We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.

Strategic Solutions for Informed Decision-Making

Back to top

We’re here to help answer any questions about our products and services.

Contact us

Locations


United States (Head Office)

30 North Gould Street, Sheridan, WY 82801

+1-415-325-5166

Australia

63 Fiona Drive, Tamworth, NSW

+61 448 06 17 27

India

C130 Sector 2 Noida, Uttar Pradesh 201301

+91-858-608-1494

Philippines

40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.

+63 287899028, +63 967 048 3306

United Kingdom

6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London

+44-753-713-2163

Vietnam

193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City

+84865399124